Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 09:43AM EDT. Market open.
| Previous Close | 65.33 |
| Open | 65.53 |
| Bid | 65.05 x 200 |
| Ask | 65.24 x 100 |
| Day's Range | 64.42 - 65.53 |
| 52 Week Range | 64.42 - 87.87 |
| Volume | |
| Avg. Volume | 7,395,556 |
| Market Cap | 81.203B |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 180.89 |
| EPS (TTM) | 0.36 |
| Earnings Date | Apr 25, 2024 |
| Forward Dividend & Yield | 3.08 (4.71%) |
| Ex-Dividend Date | Jun 14, 2024 |
| 1y Target Est | 81.84 |
ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
- Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
Business WireGilead Sciences to Present at Upcoming Investor Conferences
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
© 2024 Yahoo. All rights reserved.